rethinkPeptides Search
Menu
Study breakdown

Discovery of a Unique Opioid Receptor That Controls Immune Cell Activation

In VitroPreliminary evidence
The takeaway

A newly identified opioid receptor subtype (mu3) found on immune cells responds to morphine-like compounds and releases nitric oxide, revealing a direct link between opioid signaling and immune regulation.

Alkaloid-selective

Unlike classical opioid receptors, mu3 responds to morphine and codeine but not endogenous opioid peptides like endorphins

What the researchers found

The mu3 receptor on immune cells selectively binds opiate alkaloids (not endogenous opioid peptides), triggers nitric oxide release via constitutive nitric oxide synthase, and is present on macrophages, astrocytes, and leukemia cells.

Why it matters

Understanding how opioid receptors on immune cells work is crucial for managing the immunosuppressive effects of opioid medications and could reveal new therapeutic targets for immune modulation.

How the study worked

In-vitro binding studies and functional assays on macrophages, astrocytes, and HL-60 leukemia cells to characterize mu3 receptor properties, selectivity, and signaling pathways.

What this study cannot tell us

In-vitro study using cell lines and cultured cells. The mu3 receptor's role in whole-organism immune function was not assessed. Relevance to in-vivo immune suppression by opioids needs confirmation.

How to read the evidence

Preliminary in-vitro evidence characterizing a novel receptor. Well-documented binding studies but lacks in-vivo confirmation of functional significance.

When this study was published

Published in 1998. The mu3 receptor concept has been debated in subsequent literature, with some aspects confirmed and others requiring further validation.

The bigger picture

The immune system and opioid system are deeply interconnected. The mu3 receptor provides a molecular explanation for why opioid drugs suppress immune function, which has implications for pain management, addiction medicine, and understanding immune regulation.

Questions still open

  • Could mu3-selective antagonists prevent opioid-induced immune suppression without blocking pain relief?
  • Does chronic opioid use alter mu3 receptor expression on immune cells?
  • Is mu3 receptor signaling involved in the immune changes seen in opioid addiction?

Common questions

Why do opioids affect the immune system?
Immune cells have opioid receptors, including the mu3 subtype described here. When opioid drugs activate these receptors, they trigger nitric oxide release that suppresses immune cell activity, potentially increasing infection risk.
Is this relevant to people taking opioid pain medications?
Yes. Understanding the mu3 receptor could eventually lead to opioid drugs that relieve pain without suppressing immunity, though that goal has not yet been achieved.

Read the original research

Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.

Advances in experimental medicine and biology, 437, 137-48

Citation

Makman, M H; Dobrenis, K; Surratt, C K. (1998). Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.. Advances in experimental medicine and biology, 437, 137-48.